Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nanofarma Development

2011 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Provider of drug development services. The company specializes in oral drug delivery systems based on nanotechnology. The system is a microcontainers made from specially degradable biopolymers, which have the ability to attach to specified parts of the gastrointestinal tract and protect the active ingredient from the destructive action of proteolytic enzymes.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Acquirer
Izvarino Pharma
Primary Office
  • Vosstaniya ulitsa 100
  • Kazan, 420095
  • Russia

Nanofarma Development Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Nanofarma Development‘s full profile, request access.

Request full access to PitchBook

Nanofarma Development Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Nanofarma Development‘s full profile, request access.

Request full access to PitchBook